51
|
Agakishiev G, Arnold O, Balanda A, Belver D, Belyaev AV, Berger-Chen JC, Blanco A, Böhmer M, Boyard JL, Cabanelas P, Chernenko S, Dybczak A, Epple E, Fabbietti L, Fateev OV, Finocchiaro P, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Göbel K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Heinz T, Hennino T, Holzmann R, Ierusalimov A, Iori I, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Kornakov G, Kotte R, Krása A, Krizek F, Krücken R, Kuc H, Kühn W, Kugler A, Kurepin A, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Liu T, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michalska B, Michel J, Müntz C, Müntzer R, Naumann L, Pachmayer YC, Palka M, Parpottas Y, Pechenov V, Pechenova O, Pietraszko J, Przygoda W, Ramstein B, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Schmah A, Schwab E, Siebenson J, Sobolev YG, Spataro S, Spruck B, Ströbele H, Stroth J, Sturm C, Tarantola A, Teilab K, Tlusty P, Traxler M, Trebacz R, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky YV. Subthreshold Ξ^{-} production in collisions of p(3.5 GeV)+Nb. PHYSICAL REVIEW LETTERS 2015; 114:212301. [PMID: 26066429 DOI: 10.1103/physrevlett.114.212301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Indexed: 06/04/2023]
Abstract
Results on the production of the double strange cascade hyperon Ξ^{-} are reported for collisions of p(3.5 GeV)+Nb, studied with the High Acceptance Di-Electron Spectrometer (HADES) at SIS18 at GSI Helmholtzzentrum for Heavy-Ion Research, Darmstadt. For the first time, subthreshold Ξ^{-} production is observed in proton-nucleus interactions. Assuming a Ξ^{-} phase-space distribution similar to that of Λ hyperons, the production probability amounts to P_{Ξ^{-}}=[2.0±0.4(stat)±0.3(norm)±0.6(syst)]×10^{-4} resulting in a Ξ^{-}/(Λ+Σ^{0}) ratio of P_{Ξ^{-}}/P_{Λ+Σ^{0}}=[1.2±0.3(stat)±0.4(syst)]×10^{-2}. Available model predictions are significantly lower than the measured Ξ^{-} yield.
Collapse
|
52
|
Thuss-Patience PC, Al-Batran SE, Siveke JT, Homann N, Malfertheiner P, Glaeser D, Stein A, Tamm I, Daum S, Potenberg J, Florschütz A, Vogel A, Ridwelski K, Ritgen M, Geissler M, Schmalenberg H, Schlattmann P, Lorenz M, Breithaupt K, Pichlmeier U. Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie). J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.4033] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
53
|
Lorenz M, Koschate J, Kaufmann K, Kreye C, Mertens M, Kuebler WM, Baumann G, Gossing G, Marki A, Zakrzewicz A, Miéville C, Benn A, Horbelt D, Wratil PR, Stangl K, Stangl V. Does cellular sex matter? Dimorphic transcriptional differences between female and male endothelial cells. Atherosclerosis 2015; 240:61-72. [DOI: 10.1016/j.atherosclerosis.2015.02.018] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2014] [Revised: 01/21/2015] [Accepted: 02/09/2015] [Indexed: 12/21/2022]
|
54
|
Mähler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M, Zimmermann BF, Krannich A, Paul F, Boschmann M. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. Am J Clin Nutr 2015; 101:487-95. [PMID: 25733633 DOI: 10.3945/ajcn.113.075309] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Muscle weakness and fatigue are common symptoms in multiple sclerosis (MS). Green tea catechins such as (-)epigallocatechin-3-gallate (EGCG) are known to improve energy metabolism at rest and during exercise. OBJECTIVE We tested the hypothesis that EGCG improves energy metabolism and substrate utilization in patients with MS. DESIGN Eighteen patients (8 men) with relapsing-remitting MS (expanded disability status scale score <4.5, all receiving glatiramer acetate) participated in this randomized, double-blind, placebo-controlled, crossover trial at a clinical research center. All patients received EGCG (600 mg/d) and placebo over 12 wk (4-wk washout in between). After each intervention, fasting and postprandial energy expenditure (EE), as well as fat oxidation (FAOx) and carbohydrate oxidation (CHOx) rates, were measured either at rest or during 40 min of exercise (0.5 W/kg). At rest, blood samples and microdialysates from adipose tissue and skeletal muscle were also taken. RESULTS At rest, postprandial EE and CHOx, as well as adipose tissue perfusion and glucose supply, were significantly lower in men but higher in women receiving EGCG compared with placebo. During exercise, postprandial EE was lower after EGCG than after placebo, indicating an increased working efficiency (men > women). After placebo, exercise EE was mainly fueled by FAOx in both men and women. After EGCG, there was a shift to a higher and more stable CHOx during exercise in men but not in women. CONCLUSIONS Our data indicate that EGCG given to patients with MS over 12 wk improves muscle metabolism during moderate exercise to a greater extent in men than in women, possibly because of sex-specific effects on autonomic and endocrine control.
Collapse
|
55
|
Przygoda W, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan B, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. Investigating hadronic resonances in pp interactions with HADES. EPJ WEB OF CONFERENCES 2015. [DOI: 10.1051/epjconf/20159700024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
56
|
Epple E, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. Highlights of Resonance Measurements With HADES. EPJ WEB OF CONFERENCES 2015. [DOI: 10.1051/epjconf/20159700015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
57
|
Greyling A, Ras RT, Zock PL, Lorenz M, Hopman MT, Thijssen DHJ, Draijer R. The effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trials. PLoS One 2014; 9:e103247. [PMID: 25079225 PMCID: PMC4117505 DOI: 10.1371/journal.pone.0103247] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2014] [Accepted: 06/26/2014] [Indexed: 01/08/2023] Open
Abstract
Objective Epidemiological evidence has linked consumption of black tea, produced from Camellia sinensis, with a reduced risk of cardiovascular diseases. However, intervention studies on the effects of tea consumption on blood pressure (BP) have reported inconsistent results. Our objective was to conduct a systematic literature review with meta-analysis of controlled human intervention studies examining the effect of tea consumption on BP. Methods We systematically searched Medline, Biosis, Chemical Abstracts and EMBASE databases through July 2013. For inclusion, studies had to meet the following pre-defined criteria: 1) placebo controlled design in human adults, 2) minimum of 1 week black tea consumption as the sole intervention, 3) reported effects on systolic BP (SBP) or diastolic BP (DBP) or both. A random effects model was used to calculate the pooled overall effect of black tea on BP. Results Eleven studies (12 intervention arms, 378 subjects, dose of 4–5 cups of tea) met our inclusion criteria. The pooled mean effect of regular tea ingestion was −1.8 mmHg (95% CI: −2.8, −0.7; P = 0.0013) for SBP and −1.3 mmHg (95% CI: −1.8, −0.8; P<0.0001) for DBP. In covariate analyses, we found that the method of tea preparation (tea extract powders versus leaf tea), baseline SBP and DBP, and the quality score of the study affected the effect size of the tea intervention (all P<0.05). No evidence of publication bias could be detected. Conclusions Our meta-analysis indicates that regular consumption of black tea can reduce BP. Although the effect is small, such effects could be important for cardiovascular health at population level.
Collapse
|
58
|
Lorenz M, Paul F, Moobed M, Baumann G, Zimmermann BF, Stangl K, Stangl V. The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo. Eur J Pharmacol 2014; 740:645-51. [PMID: 24972245 DOI: 10.1016/j.ejphar.2014.06.014] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2014] [Revised: 06/12/2014] [Accepted: 06/17/2014] [Indexed: 12/22/2022]
Abstract
Catechol-O-methyltransferase (COMT) inactivates many endogenous and exogenous compounds by O-methylation. Therefore, it represents a major enzyme of the metabolic pathway with important biological functions in hormonal and drug metabolism. The tea catechin epigallocatechin-3-gallate (EGCG) is known to inhibit COMT enzymatic activity in vitro. Based on beneficial in vitro results, EGCG is extensively used in human intervention studies in a variety of human diseases. Owing to its low bioavailability, rather high doses of EGCG are frequently applied that may impair COMT activity in vivo. Enzymatic activities of four functional COMT single-nucleotide polymorphisms (SNPs) were determined in red blood cells (RBCs) in 24 healthy human volunteers (14 women, 10 men). The subjects were supplemented with 750 mg of EGCG and EGCG plasma levels and COMT enzyme activities in erythrocytes were measured before and 2 h after intervention. The homozygous Val→Met substitution in the SNP rs4680 resulted in significantly decreased COMT activity. Enzymatic COMT activities in RBCs were also affected by the other three COMT polymorphisms. EGCG plasma levels significantly increased after intervention. They were not influenced by any of the COMT SNPs and different enzyme activities. Ingestion of 750 mg EGCG did not result in impairment of COMT activity. However, COMT activity was significantly increased by 24% after EGCG consumption. These results indicate that supplementation with a high dose of EGCG does not impair the activity of COMT. Consequently, it may not interfere with COMT-mediated metabolism and elimination of exogenous and endogenous COMT substrates.
Collapse
|
59
|
Leclair N, Lorenz M, Sorge I, Ritter L, Hirsch FW. Erscheinungsmuster von Virchow-Robin-Räumen bei Kindern und Jugendlichen im MRT: eine retrospektive Analyse von 208 Fällen. ROFO-FORTSCHR RONTG 2014. [DOI: 10.1055/s-0034-1373108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
60
|
Kurilkin A, Arnold O, Atomssa ET, Behnke C, Belyaev A, Berger-Chen JC, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev YG, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Yurevich S, Zanevsky Y. Measurement of the quasi free np→ npπ+π−and np→ ppπ−π0reactions at 1.25 GeV With HADES. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20148102009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
61
|
Ramstein B, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. HADES results in elementary reactions. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20148101003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
62
|
Pietraszko J, Agakishiev G, Behnke C, Belver D, Belyaev A, Berger-Chen J, Blanco A, Blume C, Böhmer M, Cabanelas P, Chernenko S, Dritsa C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Huck P, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Siebenson J, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky Y. In-medium hadron properties measured with HADES. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20146604023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
63
|
Lorenz M, Agakishiev G, Behnke C, Belver D, Belyaev A, Berger-Chen J, Blanco A, Blume C, Böhmer M, Cabanelas P, Chernenko S, Dritsa C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Huck P, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Siebenson J, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky Y. Low mass dielectrons radiated off cold nuclear matter measured with HADES. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20146609011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
64
|
Abstract
Green and black teas contain different biologically active polyphenolic compounds that might offer protection against a variety of human diseases. Although promising experimental and clinical data have shown protective effects, limited information is available on how these beneficial effects of tea polyphenols are mediated at the cellular level. Evidence is accumulating that catechins in green tea as well as theaflavins and thearubigins from black tea are the substances responsible for the physiologic effects of tea in vitro. The green tea catechin epigallocatechin-3-gallate (EGCG) is generally considered to be the biologically most active compound in vitro. The changes in the activities of various protein kinases, growth factors, and transcription factors represent a common mechanism involved in cellular effects of tea polyphenols. In addition to modification of intracellular signaling by activation of cellular receptors, it was shown that, at least for EGCG, tea polyphenols can enter the cells and directly interact with their molecular targets within cells. There, they frequently result in opposite effects in primary compared with tumor cells. Although tea polyphenols were long regarded as antioxidants, research in recent years has uncovered their prooxidant properties. The use of high nonphysiologic concentrations in many cell culture studies raises questions about the biological relevance of the observed effects for the in vivo situation. Efforts to attribute functional effects in vivo to specific molecular targets at the cellular level are still ongoing.
Collapse
|
65
|
Lorenz M, Koschate J, Kaufmann K, Kreye C, Mertens M, Kuebler WM, Baumann G, Gossing G, Stangl K, Stangl V. Does cellular sex matter? Dimorphic transcriptional differences between female and male endothelial cells. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht307.p618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
66
|
Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fritsch M, Gyrd-Hansen M, Rensing-Ehl A, Vraetz T, Grimbacher B, Salzer U, Fuchs I, Ufheil H, Belohradsky BH, Hassan A, Cale CM, Elawad M, Strahm B, Schibli S, Lauten M, Kohl M, Meerpohl JJ, Rodeck B, Kolb R, Eberl W, Soerensen J, von Bernuth H, Lorenz M, Schwarz K, Zur Stadt U, Ehl S. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol 2013; 149:133-41. [PMID: 23973892 DOI: 10.1016/j.clim.2013.07.004] [Citation(s) in RCA: 124] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2013] [Revised: 07/14/2013] [Accepted: 07/23/2013] [Indexed: 02/08/2023]
Abstract
X-linked inhibitor of apoptosis (XIAP) deficiency caused by mutations in BIRC4 was initially described in patients with X-linked lymphoproliferative syndrome (XLP) who had no mutations in SH2D1A. In the initial reports, EBV-associated hemophagocytic lymphohistiocytosis (HLH) was the predominant clinical phenotype. Among 25 symptomatic patients diagnosed with XIAP deficiency, we identified 17 patients who initially presented with manifestations other than HLH. These included Crohn-like bowel disease (n=6), severe infectious mononucleosis (n=4), isolated splenomegaly (n=3), uveitis (n=1), periodic fever (n=1), fistulating skin abscesses (n=1) and severe Giardia enteritis (n=1). Subsequent manifestations included celiac-like disease, antibody deficiency, splenomegaly and partial HLH. Screening by flow cytometry identified 14 of 17 patients in our cohort. However, neither genotype nor protein expression nor results from cell death studies were clearly associated with the clinical phenotype. Only mutation analysis can reliably identify affected patients. XIAP deficiency must be considered in a wide range of clinical presentations.
Collapse
|
67
|
Cahoon JE, Eisenhauer DE, Elmore RW, Roeth FW, Doupnik B, Selley RA, Ferguson RB, Lorenz M, Frank K, Young LJ. Corn Yield Response to Tillage with Furrow Irrigation. ACTA ACUST UNITED AC 2013. [DOI: 10.2134/jpa1999.0269] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
68
|
Spillmann F, van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP, Tschöpe C. LXR AGONISM IMPROVES TNF-ALPHA-INDUCED ENDOTHELIAL DYSFUNCTION. J Am Coll Cardiol 2013. [DOI: 10.1016/s0735-1097(13)60643-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
69
|
Mähler A, Mandel S, Lorenz M, Ruegg U, Wanker EE, Boschmann M, Paul F. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J 2013; 4:5. [PMID: 23418936 PMCID: PMC3585739 DOI: 10.1186/1878-5085-4-5] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2012] [Accepted: 01/25/2013] [Indexed: 12/12/2022]
Abstract
Neurodegenerative disorders show an increasing prevalence in a number of highly developed countries. Often, these diseases require life-long treatment mostly with drugs which are costly and mostly accompanied by more or less serious side-effects. Their heterogeneous manifestation, severity and outcome pose the need for individualised treatment options. There is an intensive search for new strategies not only for treating but also for preventing these diseases. Green tea and green tea extracts seem to be such a promising and safe alternative. However, data regarding the beneficial effects and possible underlying mechanism, specifically in clinical trials, are rare and rather controversial or non-conclusive. This review outlines the existing evidence from preclinical studies (cell and tissue cultures and animal models) and clinical trials regarding preventive and therapeutic effects of epigallcatechin-3-gallate in neurodegenerative diseases and considers antioxidative vs. pro-oxidative properties of the tea catechin important for dosage recommendations.
Collapse
|
70
|
Szklenar M, Kalkowski J, Stangl V, Lorenz M, Rühl R. Eicosanoids and Docosanoids in Plasma and Aorta of Healthy and Atherosclerotic Rabbits. J Vasc Res 2013; 50:372-82. [DOI: 10.1159/000350865] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2012] [Accepted: 03/17/2013] [Indexed: 11/19/2022] Open
|
71
|
Lorenz M. The Role of Individual Tea Compounds in Cardiovascular Protective Effects of Green and Black Tea. TEA IN HEALTH AND DISEASE PREVENTION 2013:829-840. [DOI: 10.1016/b978-0-12-384937-3.00070-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
72
|
Lorenz M. Ganzheitlich rehabilitierende Prozesspflege nach den AEDL. PFLEGEWISSEN STROKE UNIT 2013:131-139. [DOI: 10.1007/978-3-642-29995-7_11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
73
|
Kurilkin P, Agakishiev G, Behnke C, Belver D, Belyaev A, Berger-Chen J, Blanco A, Blume C, Böhmer M, Cabanelas P, Chernenko S, Dritsa C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Holzmann R, Huck P, Höhne C, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kurepin A, Kurilkin A, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Siebenson J, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky Y. The dp-elastic cross section measurement at the deuteron kinetic energy of 2.5 GeV. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20123709021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
74
|
Breithaupt K, Bichev D, Lorenz M, Bohnen D, Dogan Y, Schlattmann P, Al-Batran SE, Moehler MH, Thuss-Patience PC. PaFLO: Pazopanib with 5-fluorouracil, leucovorin, and oxaliplatin (FLO) as first-line treatment in advanced gastric cancer: A randomized phase II study of the Arbeitsgemeinschaft internistische Onkologie (AIO). J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.tps4138] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
TPS4138 Background: VEGF inhibition in gastric cancer shows promising improvement of remission rate and progression-free survival (Ohtsu et al., JCO 2011). Pazopanib is an orally available tyrosine kinase inhibitor (TKI) selectively inhibiting VEGFR-1, -2, -3, c-kit and PDGFR. It is approved for treating renal cell cancer. A phase-I trial showed good tolerability of pazopanib with full-dose FOLFOX in solid tumors (Brady et al., ASCO, 2009). FLO is a widely used combination for advanced gastric cancer recommended in national guidelines. Methods: 75 Patients with HER-2-negative locally advanced or metastatic adenocarcinoma of the stomach or the gastro-esophageal junction will be randomized in a 2:1 ratio to A: FLO (F 2600mg/m2 as 24h infusion, L 200mg/m2, O 85 mg/m2) d1 + pazopanib (800mg) d1-14 and B: FLO; repeated for 12 2-week cycles, followed by a maintenance therapy with pazopanib alone in A and an observation period in B until disease progression. Primary endpoint is progression-free survival rate (PFSR) at 6 months, secondary endpoints are PFSR at 9 and 12 months, median PFS, response rate, duration of response, toxicity, tolerability and overall survival. Additionally, we evaluate the predictive and prognostic relevance of PIGF, VEGF, and the respective soluble receptors sVEGFR1 and sVEGFR2 as biomarkers for clinicopathological parameters, clinical response to treatment and tumor volume change. Based on a phase-III trial demonstrating a 6-month PFSR of 44% with FLO (Al-Batran et al., 2008), we estimate a 6-month PFSR of 55% in the experimental group. Given an alpha error of 0.1 and a beta error of 0.2 in a Simon 2-stage minimax design, in the first stage ≥12 of 30 patients need to be progression free at 6 months to continue and after the second stage ≥25 of 50 patients should be progression free at 6 months to justify further evaluation. Randomization is performed to estimate selection bias according to pazopanib-specific exclusion criteria for comparison with historical data. Study protocol received ethics committee approval in November 2011 and is currently recruiting patients in 15 AIO centers.
Collapse
|
75
|
Lorenz M, Fechner M, Kalkowski J, Fröhlich K, Trautmann A, Böhm V, Liebisch G, Lehneis S, Schmitz G, Ludwig A, Baumann G, Stangl K, Stangl V. Effects of lycopene on the initial state of atherosclerosis in New Zealand White (NZW) rabbits. PLoS One 2012; 7:e30808. [PMID: 22295112 PMCID: PMC3266285 DOI: 10.1371/journal.pone.0030808] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2011] [Accepted: 12/21/2011] [Indexed: 11/25/2022] Open
Abstract
Background Lycopene is the main carotenoid in tomatoes, where it is found in high concentrations. Strong epidemiological evidence suggests that lycopene may provide protection against cardiovascular diseases. We therefore studied the effects of lycopene on diet-induced increase in serum lipid levels and the initiation of atherosclerosis in New Zealand White (NZW) rabbits. Methodology/Principal Findings The animals, divided into four groups of 9 animals each, were fed either a standard diet, a high-cholesterol diet containing 0.5% cholesterol, a high-cholesterol diet containing placebo beadlets, or a high-cholesterol diet plus 5 mg/kg body weight/day of lycopene (in the form of lycopene beadlets), for a period of 4 weeks. We found significantly elevated lycopene plasma levels in the animal group treated with lycopene beadlets. Compared to the high-cholesterol and the placebo group, this was associated with a significant reduction of 50% in total cholesterol and LDL cholesterol serum levels in the lycopene group. The amount of cholesteryl ester in the aorta was significantly decreased by lycopene. However, we did not observe a significant decrease in the extent of aortic surface lipid accumulation in the lycopene group. In addition, no differences in the intima-media thickness among groups were observed. Endothelial-dependent and endothelial-independent vasodilation in isolated rabbit aortic and carotid rings did not differ among any of the animal groups. Conclusions Lycopene supplementation for 4 weeks increased lycopene plasma levels in the animals. Although we found strongly reduced total and LDL cholesterol serum levels as well as significantly lower amounts of cholesteryl ester in the aortae in the lycopene-treated group, no significant differences in initial lesions in the aortae were detected.
Collapse
|